Raymond James initiates QXO stock with Outperform rating on acquisition strategy
Paul L. Alpern, VP and General Counsel at Arteris, Inc. (NASDAQ:AIP), a company with a market capitalization of $386 million, sold 258 shares of common stock on September 2, 2025, for approximately $2,306.
The shares were sold at a price of $8.9417, close to the current trading price of $8.84. The transaction was to cover the executive’s tax obligations related to the vesting of restricted stock units. Following the transaction, Alpern directly owns 76,289 shares of Arteris , Inc. The stock has declined about 9% over the past week, though analysts maintain price targets ranging from $11 to $16. InvestingPro data shows the company maintains impressive gross profit margins of 90%, with additional insights available through the platform’s comprehensive Pro Research Report.
In other recent news, Arteris Inc. reported its second-quarter 2025 earnings, revealing revenue figures that exceeded expectations. The company achieved a revenue of $16.5 million, surpassing the forecast of $16.35 million. However, the earnings per share were slightly lower than anticipated, at -$0.11 compared to the predicted -$0.10. In another development, Arteris announced its membership in the Ultra Accelerator Link Consortium, which aims to advance technical standards for AI accelerators. The consortium includes major technology firms such as AMD, AWS, Google, Intel, Meta, and Microsoft. These recent developments highlight Arteris’s strategic moves and financial performance in the current period.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.